Evidence map›Paper›PMID 39065574›Full record

ArticlePharmaceutics2024

Palmitoylethanolamide-Incorporated Elastic Nano-Liposomes for Enhanced Transdermal Delivery and Anti-Inflammation.

Chuanpeng Ren, Yanyun Ma, Yizhen Wang, Dan Luo, Yanhan Hong, Xinyuan Zhang, Hexiang Mei, Wei Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chuanpeng RenThe Institute of Biocelline Precision Dermatology, Shanghai 200031, China.
Yanyun MaHuman Phenome Institute, Fudan University, Shanghai 201210, China.
Yizhen WangThe Institute of Biocelline Precision Dermatology, Shanghai 200031, China.
Dan LuoWuhan Bestcarrier Biotechnology Co., Ltd., Wuhan 430075, China.
Yanhan HongWuhan Bestcarrier Biotechnology Co., Ltd., Wuhan 430075, China.
Xinyuan ZhangShanghai Skinshield Clinical Testing and Technological Research Ltd., Shanghai 201210, China.
Hexiang MeiThe Institute of Biocelline Precision Dermatology, Shanghai 200031, China.
Wei LiuNational Engineering Research Center for Nanomedicine, Huazhong University of Science and Technology, Wuhan 430074, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palmitoylethanolamide (PEA) exhibits multiple skincare functions such as anti-nociceptive and anti-inflammatory effects. However, its topical application is limited due to its difficulty in bypassing the

Indexed as

anti-inflammatoryanti-nociceptiveelastic nano-liposomespalmitoylethanolamidetransdermal deliverytransient receptor potential vanilloid 1

Identifiers

PMID39065574
PMCPMC11280357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.